Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Palantir Technologies (PLTR) is the top-performing stock in the S&P 500 to start 2025, soaring 50% so far this year. But the ...

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price ...

Resmed has its origins in the 1980s, when Sydney sleep expert Dr Colin Sullivan converted a vacuum cleaner to deal with the ...

Two healthcare stocks that may or may not be boring, but that regardless look like strong growth stocks to invest in this ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Some of the market’s biggest winners start off as the smallest players. While trillion-dollar tech giants like the ...

Viking Therapeutics stock jumped higher last year because it looks like a dual GLP-1/GIP agonist it's developing could ...

Terns Pharmaceuticals' TERN-701 and TERN-601 face challenges in CML and obesity. Find out why TERN stock is not a strong buy amid tough competition.

This week was loaded with earnings releases of many large drugmakers. Novo Nordisk NVO, Merck MRK, Pfizer PFE, Eli Lilly LLY, ...